PD40 sGaw with deep inhalation as alternative for PD20 FEV1

L. Natalia (Amsterdam, Netherlands), M. Van Der Plas (The Hague, Netherlands), P. Bresser (Amsterdam, Netherlands)

Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD
Session: Clinical characteristics and diagnostic tools for phenotyping asthma and COPD
Session type: E-poster session
Number: 193
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Natalia (Amsterdam, Netherlands), M. Van Der Plas (The Hague, Netherlands), P. Bresser (Amsterdam, Netherlands). PD40 sGaw with deep inhalation as alternative for PD20 FEV1. 193

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The influence of FVC manoeuvres on consecutive FEV1 values during methacholine challenge
Source: Eur Respir J 2004; 24: Suppl. 48, 587s
Year: 2004

sGaw as an alternative for FEV1 in the measurement of airway responsiveness to methacholine in patients experiencing chronic cough
Source: Annual Congress 2011 - Lung function today and tomorrow I
Year: 2011


A comparison of the response to inhaled histamine measured with FEV1 and sGaw in healthy subjects
Source: Annual Congress 2003 - Assessing airway function: practicalities and clinical applications
Year: 2003


The (un)importance of the time-interval between inhalation and FEV1 measurement in a methacholine challenge test
Source: Eur Respir J 2004; 24: Suppl. 48, 183s
Year: 2004

Comparison of FEV1 and PEF values in cough variant asthma during methacholine challenge test
Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control
Year: 2010


Maximally attained level of FEV1 and FEV1 decline determine airway hyperresponsiveness in adults
Source: Eur Respir J 2003; 22: Suppl. 45, 17s
Year: 2003

Comparison of sensitivity and variability of sGaw and FEV1 for measuring bronchodilation in healthy and asthmatic subjects
Source: Eur Respir J 2004; 24: Suppl. 48, 338s
Year: 2004

FEV6 and FEV1/FEV6 as an alternative for FVC and FEV1/FVC in monitoring response to prednisolone treatment
Source: Annual Congress 2010 - Quality measurement and improvement in lung function
Year: 2010


Evaluation of the response of airway obstruction to short-acting inhaled broncodilators with using FIV1 and FEV1 in COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 290s
Year: 2005

Within session variability of FEV1 and FVC pre- and post-bronchodilation
Source: International Congress 2019 – Quality, performance and interpretation of lung function testing
Year: 2019


FEV6 as an alternative for FVC in predicting airway obstruction
Source: Eur Respir J 2006; 28: Suppl. 50, 220s
Year: 2006

IsovolumeFEF25-75%6 and FEV1 for identifying bronchodilator response
Source: Eur Respir J 2006; 28: Suppl. 50, 156s
Year: 2006

Ratio between forced expiratory flow between 25% and 75% of VC and FVC as a determinant of airway reactivity and sensitivity to methacholine
Source: Eur Respir J 2006; 28: Suppl. 50, 219s
Year: 2006

Bronchyal hyperreactivity estimated by bronchodilatator test and FEF25-75/FVC ratio
Source: Eur Respir J 2007; 30: Suppl. 51, 744s
Year: 2007

Comparison of variations of FEV1 and forced oscillation technique during methacholine challenge
Source: Eur Respir J 2004; 24: Suppl. 48, 339s
Year: 2004

FEV6 and FEV1/FEV6 have higher association with small airway function and oxygen saturation than FVC and FEV1/FVC in patients with asthma.
Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers
Year: 2020

Differentiation of bronchodilator effects of indacaterol and formoterol by FEV1 and inspiratory capacity (IC) in patients with COPD
Source: Annual Congress 2007 - New drugs for COPD
Year: 2007



Time of maximal spirometric change after bronchodilator inhalation
Source: International Congress 2017 – Discussion of techniques and technologies in lung function
Year: 2017


How to interpret reduced forced expiratory volume in 1 s (FEV1)/vital capacity ratio with normal FEV1
Source: Eur Respir J 2009; 33: 1396-1402
Year: 2009